Cell MedX Corp

Recent News

  • FDA Submission and Corporate Update

    Carson City, Nevada--(Newsfile Corp. - September 20, 2022) - Cell MedX Corp. (OTC PINK: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is providing the following corporate update including the U.S. Food and Drug Administration (FDA) premarket notification (510(k)) submission.FDA Premarket Notification (510(k)) Update; In September 2021, Cell MedX filed its US premarket notification (510(k)) submission with the FDA. The FDA...

    2022-09-20 8:30 AM EDT
  • Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO

    Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to issue the following letter from Mr. Dwayne Yaretz the Company's new CEO.Mr. Yaretz, CEO;Having recently accepted the positions of CEO and Director of Cell MedX, I wanted to introduce myself to you, highlight the Company's most recent accomplishments and...

    2022-06-27 8:00 AM EDT
  • Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director

    Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has appointed Mr. Dwayne Yaretz to the Board of Directors and as Chief Executive Officer. Mr. Yaretz replaces Mr. McEnulty, as CEO of the Company. Mr. McEnulty will continue to serve as a director of...

    2022-04-27 9:00 AM EDT
  • Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC

    Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it will be participating as an exhibitor at the 29th Annual Wellness Show held at Vancouver Convention Centre, East Building, on March 26th - 27th. The Wellness Show is a host of Western Canada's biggest and...

    2022-03-24 8:00 AM EDT
  • FDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems

    Carson City, Nevada--(Newsfile Corp. - November 15, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that the U.S. Food and Drug Administration (FDA) has acknowledged the receipt of the premarket notification (510K) for the eBalance® Home System and eBalance® Pro System. The submission is in the initial review stage and...

    2021-11-15 8:30 AM EST
  • Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark

    Carson City, Nevada--(Newsfile Corp. - September 17, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has submitted a premarket notification (510K) to the U.S. Food and Drug Administration (FDA) for the eBalance® Home System and eBalance® Pro System.The eBalance® Pro System and eBalance® Home System, are microcurrent electrotherapy systems...

    2021-09-17 9:00 AM EDT
  • Cell MedX Corp. Converts Debt to Shares, Closes Non-Brokered Private Placement Financing, and Engages Investor Relations Consultants

    Carson City, Nevada--(Newsfile Corp. - May 26, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on May 25, 2021, the Company issued 2,484,500 common shares of the Company (the "Shares") on conversion of $496,900 the Company owed its debt holders under 6% demand notes payable and non-interest-bearing advances. In...

    2021-05-26 8:00 AM EDT
  • Cell MedX Corp. Signs Extension Agreement with Think Ink Marketing

    Carson City, Nevada--(Newsfile Corp. - September 24, 2020) - Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, announced today that it has signed an extension agreement with Think Ink Marketing Data & Email Services, Inc. ("Think Ink") to provide public relations services in an effort to increase public awareness of the Company and its...

    2020-09-24 8:00 AM EDT